Aptose Announces FDA Allowance of Investigational New Drug Application for CG-806

NEXT STORY
Translate Bio to Participate in Upcoming Investor Conferences
PREV STORY
XORTX Shares Findings of New Diabetes Study Supporting Uric Acid as an Independent Risk Factor
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Final Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Lead Plaintiff Deadline in Securities Fraud Class Action Lawsuit Filed Against Novavax, Inc. (NVAX)

author_avatar
NASDAQ Market News

Cancer Genetics, Inc. to Receive $1.0 Million in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program

RUTHERFORD, N.J., Feb. 22, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) an emerging ...

author_avatar
NASDAQ Market News

Number of Shares and Voting Rights of Innate Pharma as of May 1, 2021

author_avatar
NASDAQ Market News